This week, the Food and Drug Administration (FDA) approved two drugs that made the headlines because they were drugs that[…]
Read more
This week, the Food and Drug Administration (FDA) approved two drugs that made the headlines because they were drugs that[…]
Read moreTo prevent the shortages that were a result of the COVID-19 pandemic, on February 24, 2021, President Biden signed Executive[…]
Read moreThe Centers for Medicare & Medicaid Services (CMS) published the final ICD-10-PCS codes and guidelines for the 2022 fiscal year[…]
Read moreCMS has announced a final ruling that will revise regulations for the Medicare Advantage (MA or Part C) program and[…]
Read moreFor over 19 years, GIRS has tracked payer trends to develop and implement market access strategies for our clients’ Products. […]
Read moreWe have created a free eBook just for you! Look at our short video for more details. You can also[…]
Read moreWatch our short video to see some of the regulatory changes happening this year to create a healthcare system that[…]
Read moreWhat does the future hold for #Medtech? Take a look at our short video with details regarding Medicare Advantage changes[…]
Read moreFor more information, email us at info@girsinc.com or call us at 901-834-9119. On December 1, 2020, the Centers for Medicare[…]
Read moreFor more information, email us at info@girsinc.com or call us at 901-834-9119. GIRS tracks payer market mergers and other trends[…]
Read more